StockData
Relay Therapeutics, Inc. logo

Relay Therapeutics, Inc. (RLAY) stock

RLAYNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 10/30
$16.47−0.80 (-4.63%)

Close on Nov 17, 2026Market cap $3.61BP/E –Yield –

Relay Therapeutics price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Relay Therapeutics's price to book ratio was 4.8× on Nov 11, 2026, against 2.2× a year earlier. Over the last 5 years it ranged from 0.6× to 5.5×, with a median of 1.8×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20264.8×+2.4
2025Dec 31, 20252.4×+1.6
2024Dec 31, 20240.8×−0.9
2023Dec 29, 20231.7×−0.1
2022Dec 30, 20221.8×−3.2
2021Dec 31, 20215.0×−0.2
2020Dec 31, 20205.2×–

More Relay Therapeutics figures

See a number that looks wrong?